Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
19.39
+0.37 (1.95%)
At close: Jan 22, 2026, 4:00 PM EST
19.01
-0.38 (-1.96%)
After-hours: Jan 22, 2026, 4:10 PM EST
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.97 billion as of January 22, 2026. Its market cap has increased by 40.78% in one year.
Market Cap
1.97B
Enterprise Value
1.61B
1-Year Change
40.78%
Ranking
Category
Stock Price
$19.39
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.97B, an increase of 179.16%. That is a compound annual growth rate of 20.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.93B | 0.26% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olema Pharmaceuticals | 2.07B |
| Dianthus Therapeutics | 2.06B |
| Aurinia Pharmaceuticals | 1.95B |
| Ardelyx | 1.94B |
| Monte Rosa Therapeutics | 1.92B |
| Vericel | 1.91B |
| MBX Biosciences | 1.85B |
| Sionna Therapeutics | 1.82B |